TRIGLYCERIDES_2 REAGENT, CONCENTRATED 10697575

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2016-08-16 for TRIGLYCERIDES_2 REAGENT, CONCENTRATED 10697575 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[52547505] Siemens healthcare diagnostics has confirmed the advia chemistry triglyceride concentrated reagent (trig_c) does not meet instructions for use (ifu) linearity claim at the upper limit of the assay range as it approaches end of shelf life for kit lot 365096. Internal testing indicates that a patient bias (-7% to -12%) may be seen at concentration levels from 550 to 600 mg/dl (6. 22 to 6. 78 mmol/l). Linearity is reduced by approximately 50% at triglyceride concentrations approaching the upper end of the extended range of 1100 mg/dl (12. 43 mmol/l). Quality control (qc) material may not detect this issue depending on the triglyceride concentrations in the qc material. Siemens internal testing has confirmed all other in date lots are currently meeting linearity ifu claims. However, as a precaution, until root cause is determined, a short term mitigation of reducing the expiration date to 6 months for all lots of advia chemistry systems triglyceride concentrated has been implemented. An urgent field safety notice (ufsn) chc16-03a. A. Ous was sent to ous customers and a urgent medical device recall (umdr) chc16-03a. A. Us was sent to us customers in august of 2016. The ufsn and umdr state that customers are to discontinue use and discard reagent kit lot 365096.
Patient Sequence No: 1, Text Type: N, H10


[52547506] Customer was running quality control and confirmed a linearity performance issue exhibiting reduced upper end recovery below 500mg/dl with advia chemistry triglycerides concentrated assay (trig_c) kit lot 365096. Customer moved to a new lot of trig_c (kit lot 379597) which performed with better recovery. System is fully functional. No further action required. There were no reports of patient intervention or adverse health consequences due to the reduced upper end recovery below 500mg/dl.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2432235-2016-00476
MDR Report Key5878237
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2016-08-16
Date of Report2016-08-16
Date of Event2016-08-10
Date Mfgr Received2016-08-10
Date Added to Maude2016-08-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLORIANN RUSSO
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145242287
Manufacturer G1RANDOX LABORATORIES LTD (REG # 8020890)
Manufacturer Street55 DIAMON ROAD
Manufacturer CityCRUMLIN, CO. ANTRIM BT29 4QY,
Manufacturer CountryUK
Single Use3
Previous Use Code3
Removal Correction Number2432235-03/09/2016-001-R
Event Type3
Type of Report3

Device Details

Brand NameTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Generic NameTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Product CodeCDT
Date Received2016-08-16
Model NumberTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Catalog Number10697575
Lot Number365096
Device Availability*
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2016-08-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.